From the wreck of the Titanic to space exploration the Titanic in the Atlantic Ocean this week, and the $250,000 per person spent on it, is an example of how extraordinary tourism around the world is for those people. It has become a matter of who can afford it.

Pfizer, an American pharmaceutical company, has entered into an agreement with the global medicine patent pool to make the corona virus-treating antiviral pixelwood more affordable in the world's poorest countries
According to the French news agency AFP, Pfizer will issue licenses to ordinary pharmaceutical companies to manufacture Pixlowood pills to supply antiviral drugs to 95 low- and middle-income countries.
Under an agreement reached with the Global Medicine Patent Pool (MPP), Pfizer will not receive royalties from ordinary pharmaceutical companies, making cheaper treatment possible.
The Geneva-based MPP is a United Nations-backed international organization working to facilitate the development of medicines for low- and middle-income countries.
The agreement with the MPP is subject to the ongoing trials of antiviral drugs and the approval of regulatory bodies.
The American pharmaceutical company Pfizer said that according to the data obtained from the ongoing trials of antiviral pill, there has been an 89% reduction in hospital admissions or deaths of Corona patients.Pfizer said the pill could prevent coronavirus exacerbation. Acute coronavirus infection in a patient can lead to hospitalization or death

1. 

According to pharmaceutical companies, pills are easier to deliver than vaccines

 

Albert Borla, chairman and chief executive of Pfizer, said: "We believe that antiviral pills can play a significant role in reducing the severity of the corona virus and in maintaining health as well as human lives
Last month, the MPP entered into a similar agreement with another American pharmaceutical company, Merck & Co., which developed the antiviral pill Molnov.
The agreement, subject to regulatory approval, will help create greater access to Molno Power in 105 low- and middle-income countries.
Pills are easier to make than vaccines, do not require cold chain for delivery and can be administered by the patient himself.